Stryker Corporation SYK shares traded higher on Monday. The stock may have been rebounding after falling last week following FDA establishment of a Digital Health Advisory Committee.
What To Know: Last Wednesday, shares of Stryker fell alongside other healthcare stocks on the announcement of the committee, which is intended to advise the U.S. Food and Drug Administration (FDA) on topics related to digital health technologies (DHTs). Shares of the stock continued to slide into Thursday following the news as well.
However, the stock began to rebound from the selloff last Friday, a move which continued on Monday.
Related Link: Why Harmony Biosciences Stock Is Trading Higher Today
SYK Price Action: Shares of SYK were flat in the after-hours session at the time of publication, according to Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
